Alzheimer disease is a medical disorder which disrupts the part of the brain that controls memory, language and thought. According to current estimates there are more than 4 million people in the United States who may have Alzheimer disease. The Alzheimer disease usually is usually found in older people and starts at the age of 65.

Alzheimer’s disease advances in two main stages which usually ranges from mild forget fullness to severe dementia. The disease usually varies from person to person. Currently there is no definitive test for Alzheimer disease treatment and only specialized research facilities runs diagnosis and provides 95% accuracy of the disease. According to current research there is no effective treatment that can be relied to halt the progression of Alzheimer disease.According to recent research some of the most common possible risk factor that lead to Alzheimer diseaseis genetic factor.And apart from drug discovery portfolio Alzheimer’sthere were several experimental drug for Alzheimer disease which showed some promising results.

Alzheimer – A common form of Dementia:
Some of the established institute for Alzheimer disease research center such as Neurodegeneration Consortium is trying to focus and learn the real cause behind the disease where they have collaborated with some of the finest research institutes such as University of Texas MD Anderson Cancer Center and MIT where they paced on the efforts to discover new drugs. The Neurodegeneration Consortium brought some of the finest experts and leaders under one roof in order to understand the real biology and discovering new age technology to make a better world.

There has been an increase in the number of Alzheimer disease in America and it is mainly found among the senior citizen what is roughly 5 million and thus now it is placed under the category of chronic diseases which includes Diabetes, cardiovascular diseases. The research organization and institutes have dedicated themselves and are on the verge to look out for Alzheimer’s disease cure in America. http://www.neurodegeneration-consortium.org/